Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Cipla
Mallinckrodt
Dow
Healthtrust
Accenture
UBS
Farmers Insurance
Argus Health

Generated: May 25, 2018

DrugPatentWatch Database Preview

Celecoxib - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for celecoxib and what is the scope of celecoxib patent protection?

Celecoxib
is the generic ingredient in two branded drugs marketed by Gd Searle, Alembic Pharms Ltd, Apotex Inc, Aurobindo Pharma Ltd, Cipla Ltd, Cspc Ouyi Pharm Co, Jubilant Generics, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, Mylan Pharms Inc, Teva, Torrent Pharms Ltd, and Watson Labs Inc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for celecoxib. Fifty-three suppliers are listed for this compound.
Pharmacology for celecoxib
Medical Subject Heading (MeSH) Categories for celecoxib
Synonyms for celecoxib
169590-42-5
184007-95-2
194044-54-7
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole
590C425
A25046
AB00052396_10
AB00052396_11
AB00052396-07
AB00052396-08
AB00052396-09
AB0012055
ABP000291
AC-4228
AC1L1E6K
ACT02648
AI-525
AKOS015842517
AM84588
AN-12211
AT-3762
BBL029086
BC209720
BCP9000507
BCPP000290
BDBM11639
Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-
benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
BIDD:GT0408
BP-30217
BRD-K02637541-001-02-4
BSPBio_003596
C-6317
C07589
C17H14F3N3O2S
CAS-169590-42-5
CCG-39354
CCRIS 8679
CCRIS 9330
Celebra
Celebra (TN)
Celebrex
Celebrex (TN)
Celebrex, Celebra, 169590-42-5
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxib 1.0 mg/ml in Acetonitrile
Celecoxib, >=98% (HPLC)
Celecoxib, European Pharmacopoeia (EP) Reference Standard
Celecoxib, pharmaceutical secondary standard; traceable to USP, PhEur
Celecoxib, United States Pharmacopeia (USP) Reference Standard
Celecoxib/Celebrex, Celebra
Celecoxib|169590-42-5|Celebrex|SC 58635
Celecoxibum
Celocoxib
CEP-33222
CHEBI:41423
CHEMBL118
cid_2662
CJ-016377
cMAP_000027
CP-598107
CPD000550473
CS-0570
CTK8H4475
D00567
D03RTS
DB00482
DivK1c_000893
DSSTox_CID_2777
DSSTox_GSID_22777
DSSTox_RID_76725
DTXSID0022777
EBD24636
Eurocox
EX-A175
FT-0080064
FT-0601628
FT-0623536
FT-0700357
GTPL2892
HE065764
HE317467
HMS1922G14
HMS2089L18
HMS2093I07
HMS2234N18
HMS3259L08
HMS3261A14
HMS3373A09
HMS3654H09
HMS502M15
HSDB 7038
HY-14398
I01-1033
IDI1_000893
J-010566
J-520011
J10035
JCX84Q7J1L
KB-76000
KBio1_000893
KBio2_000912
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
KS-00000FW2
KS-1041
LS-31667
MCULE-4750749400
Medicoxib
MFCD00941298
MLS001165684
MLS001195656
MLS001304708
MLS006011862
MolPort-002-885-815
NC00708
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCGC00091455-05
NCGC00091455-06
NCGC00091455-07
NCGC00091455-08
NCGC00091455-09
NCGC00254540-01
NCGC00259513-01
NCGC00261091-01
NCI60_041049
NINDS_000893
NSC-719627
NSC-758624
NSC719627
NSC758624
Onsenal
Onsenal (TN)
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
PF-00345549
Pfizer brand of celecoxib
PHA-00846533
Pharmakon1600-01503678
Q-200816
RL02184
RZEKVGVHFLEQIL-UHFFFAOYSA-N
s1261
SAM002589995
SBI-0051875.P002
SC 58635
SC-50829
SC-58553, SC-58635
SC-58635
SC58635
SCHEMBL3708
SMR000550473
Solexa
SPBio_001512
Spectrum_000432
SPECTRUM1503678
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
SR-01000837528
SR-01000837528-2
STL373576
SYN3015
TL8001323
Tox21_111135
Tox21_111135_1
Tox21_201964
Tox21_300599
Tox21_500406
TPI-336
UNII-JCX84Q7J1L
UNM-0000305813
US8741944, Comparative Compound
Xilebao
YM 177
YM-177
YM177
Z2210694606
ZINC2570895

US Patents and Regulatory Information for celecoxib

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd CELECOXIB celecoxib CAPSULE;ORAL 206827-002 Feb 1, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alembic Pharms Ltd CELECOXIB celecoxib CAPSULE;ORAL 204519-001 Aug 21, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lupin Ltd CELECOXIB celecoxib CAPSULE;ORAL 202240-003 Jun 9, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Micro Labs CELECOXIB celecoxib CAPSULE;ORAL 204776-004 Apr 30, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for celecoxib

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-001 Dec 31, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-004 Dec 15, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-004 Dec 15, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-003 Aug 29, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Colorcon
Dow
Fuji
Chinese Patent Office
Deloitte
Federal Trade Commission
Fish and Richardson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.